Filing Details
- Accession Number:
- 0001104659-24-078786
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-10 08:30:11
- Reporting Period:
- 2024-07-08
- Accepted Time:
- 2024-07-10 08:30:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Fortress Biotech Inc. | FBIO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
941841 | Md A Lindsay Rosenwald | C/O Fortress Biotech, Inc. 1111 Kane Concourse Suite 301 Bay Harbor Islands FL 33154 | President, Ceo & Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Series A Cumulative Perpetual Preferred Stock | Acquisiton | 2024-07-08 | 5,000 | $7.35 | 117,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price.